Flunarizine
- Generic Name
- Flunarizine
- Drug Type
- Small Molecule
- Chemical Formula
- C26H26F2N2
- CAS Number
- 52468-60-7
- Unique Ingredient Identifier
- R7PLA2DM0J
- Background
Flunarizine is a selective calcium entry blocker with calmodulin binding properties and histamine H1 blocking activity. It is effective in the prophylaxis of migraine, occlusive peripheral vascular disease, vertigo of central and peripheral origin, and as an adjuvant in the therapy of epilepsy.
- Indication
Used in the prophylaxis of migraine, occlusive peripheral vascular disease, vertigo of central and peripheral origin, and as an adjuvant in the therapy of epilepsy.
- Associated Conditions
- Severe Migraine
Douglas Tsao Maintains Buy Rating on Xenon Pharmaceuticals' Azetukalner
Douglas Tsao of H.C. Wainwright reaffirms a Buy rating for Xenon Pharmaceuticals, citing the promising efficacy and tolerability of its antiepileptic drug, azetukalner, supported by positive trial results and its impact on patients' emotional well-being.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath